Moby summary of BioHarvest Sciences Inc.'s Q3 2026 earnings call
BioHarvest Sciences Inc. (BHST) โ Live Session & Technical Brief
Updated Nov 22, 2026 6:15 AM ET ยท Prev Close $1.32
Session Regime & Catalyst Assessment
64% Signal ConvictionControlled Session Consolidation (-1.52%) in Packaged Foods
BioHarvest Sciences Inc. (BHST) is trading within a tight intraday band at $1.30 (-1.52%, 0.30x relative volume), signaling orderly institutional price discovery without an outlier shock. Relative to benchmarks, BHST is outperforming the S&P 500 by +2.12%. 14-day RSI stands at 37.2, keeping momentum in a bearish regime.
Moby summary of BioHarvest Sciences Inc.'s Q3 2026 earnings call
Price ($1.30) trades relative to 20-day SMA ($1.55) and 50-day SMA ($1.58).
Market & Sector Relative Strength
BHST outperforming the S&P 500 by +2.12%Recent BHST Catalyst Headlines
Verified WireManagement trims VINIA spending and sets a 2027 fragrance production target.
BioHarvest Sciences Inc Nasdaq Bhst reported third-quarter revenue of US 7.9 million and said its first manufacturing and supply agreement, covering 20 tons of a rare plant-based fragrance ingredient, is estimated to gen
BioHarvest Sciences Inc. BHST delivered earnings and revenue surprises of 6.25 and -18.31 , respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
1โ3 Day Expected Range & Key Level
48% Follow-ThroughMonitor volume expansion above 1.5x RVOL around $1.30 (session support) for directional breakout confirmation.
Technical Regime (BHST)
BEARISH MA TRENDRetail & Crowd Sentiment
NeutralBioHarvest Sciences reported Q1 2026 earnings with revenue growth and expanded gross margin, introducing a two-lens reporting structure for improved operational and financial clarity.
About BioHarvest Sciences Inc.
BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. This company is the industrial large-scale plant cell growth technology capable of directly and constantly producing active plant ingredients without the necessity to grow the plant itself. The company is focused on leveraging its botanical synthesis technology to develop โฆ
Get Instant BHST Catalyst Alerts
Receive an email alert when BHST triggers an unusual volume breakout, options sweep, or rating shift.
BHST Session & Catalyst FAQ
Why is BHST stock trading near flat today?
BioHarvest Sciences Inc. (BHST) is trading within a tight intraday band at $1.30 (-1.52%, 0.30x relative volume), signaling orderly institutional price discovery without an outlier shock. Relative to benchmarks, BHST is outperforming the S&P 500 by +2.12%. 14-day RSI stands at 37.2, keeping momentum in a bearish regime.
Is BHST stock a buy or sell right now?
Today's session carries a 64% catalyst conviction score on 0.30x relative volume (low participation). Our multi-factor model currently rates BHST as STRONG BUY. Review full valuation, quality, and timing signals on the BHST Buy or Sell Decision Brief โ
What is BHST's intrinsic value and expected trading range?
At $1.30, BHST's modeled 1-to-3 session range is $1.25 โ $1.35, with a key inflection level at $1.30 (session support). Compare current price against multi-year cash flow projections in the BHST Intrinsic Value & DCF Model โ and Market Cycle Phase Tracker โ
What do RSI and moving averages signal for BHST?
RSI at 37.2 reflects soft below-midline momentum. BHST trades at $1.30 relative to its 20-day SMA ($1.55) and 50-day SMA ($1.58), reflecting a bearish moving-average structure.
Tradestie Flagship Research & Market Hubs
Live institutional catalyst tape ranking liquid gainers, losers, options sweeps, and RVOL surges.
Track spot H100/B200 compute rental rates and frontier LLM inference token economics.
Wafer yield, CoWoS packaging, and HBM bill-of-materials teardown models across AI accelerators.
Monitor engineering velocity and upstream foundry wafer demand inflections across tech leaders.
Live conviction tracking, invalidation guardrails, and thesis health checks on flagship ideas.
Backtest-validated unusual options positioning and open-interest accumulation setups.
Daily ranked quantitative leaderboard with audited forward-return track record vs S&P 500.
High-yield, quality-screened cash-secured put and put-spread income candidates.